Price Transparency

Democratic advisers expect new (and some continued) healthcare policies under Biden

A Biden administration is likely to try new healthcare policy approaches and to build on some from the Trump administration, say Democratic advisers.

Rich Daly November 20, 2020

CMS finalizes requirement for hospitals to report MA plan rates

In the FY21 IPPS final rule, CMS expanded controversial negotiated-price reporting requirements.

Rich Daly November 2, 2020

Hospital finance leaders expect deteriorating payer mix, HFMA survey finds

Most hospitals expect their payer mix to shift in the next 12 months toward more Medicaid and individually insured patients.

Rich Daly November 2, 2020

Hospitals’ challenge to new transparency rule draws skepticism from appeals court

A federal appeals panel appeared hostile to many hospital arguments in a case challenging a looming price transparency requirement.

Rich Daly November 2, 2020

Requirements for drug price information added to final rule on health plan price transparency

Health plans are required by a new final rule to publicly release negotiated rates with all providers and give enrollees out-of-pocket cost information for each.

Rich Daly November 2, 2020

Deconstructing the CMS price transparency rule

By Jan. 1, 2021, hospitals and health systems must create and make public a list of standard charges for the top items and services they provide, per CMS. An executive discusses the challenges and opportunities this presents in this overview.

HFMA October 29, 2020

Hospitals predict significant shifts in payer mix, revenue cycle operations post pandemic

In an HFMA conducted survey, 151 healthcare leaders answered questions about their projections for payer mix, consumer and employee experience strategies, revenue cycle IT budgets, electronic health record satisfaction and price transparency preparedness.

HFMA October 29, 2020
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );